• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核成像在肥厚型心肌病中的应用:一篇叙述性综述

The Utility of Nuclear Imaging in Hypertrophic Cardiomyopathy: A Narrative Review.

作者信息

Pradeep Kundur Sukruth, Malik Ali, Sivalokanathan Sanjay

机构信息

Faculty of Life Sciences and Medicine, King's College London, London WC2R 2LS, UK.

Mount Sinai Health System, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

出版信息

J Clin Med. 2025 Mar 22;14(7):2183. doi: 10.3390/jcm14072183.

DOI:10.3390/jcm14072183
PMID:40217634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11989881/
Abstract

Hypertrophic cardiomyopathy (HCM) is the most common genetically inherited cardiac condition, characterized by clinical heterogeneity and a significantly increased risk of adverse cardiovascular outcomes, including sudden cardiac death. Current diagnostic methods primarily use echocardiography, often supplemented by cardiovascular magnetic resonance imaging (MRI), to assess the clinical profile of the disorder. Effective risk stratification protocols are essential for managing patients with HCM. These models rely on patient histories, imaging findings, and genetic information to evaluate the prognosis. Important factors in risk assessment include severe left ventricular hypertrophy (>30 mm), late gadolinium enhancement (>15%), or the presence of an apical aneurysm. However, these imaging techniques may lack sensitivity when it comes to detecting ischemia or microvascular dysfunction. Nuclear imaging methods, such as single-photon emission computed tomography (SPECT) and positron emission tomography (PET), offer a more comprehensive analysis of HCM. They provide valuable insights into the complex physiological mechanisms underlying the disease and facilitate early detection of functional abnormalities. This is particularly important for identifying high-risk phenotypes and understanding associated risk factors that may increase morbidity or mortality. This narrative review focuses on the role of nuclear imaging in the context of hypertrophic cardiomyopathy.

摘要

肥厚型心肌病(HCM)是最常见的遗传性心脏疾病,其特点是临床异质性以及心血管不良结局风险显著增加,包括心源性猝死。目前的诊断方法主要使用超声心动图,常辅以心血管磁共振成像(MRI),以评估该疾病的临床特征。有效的风险分层方案对于管理HCM患者至关重要。这些模型依靠患者病史、影像学检查结果和基因信息来评估预后。风险评估中的重要因素包括严重左心室肥厚(>30毫米)、钆延迟强化(>15%)或心尖部动脉瘤的存在。然而,这些成像技术在检测缺血或微血管功能障碍方面可能缺乏敏感性。核成像方法,如单光子发射计算机断层扫描(SPECT)和正电子发射断层扫描(PET),能对HCM进行更全面的分析。它们为该疾病潜在的复杂生理机制提供了有价值的见解,并有助于早期发现功能异常。这对于识别高危表型以及了解可能增加发病率或死亡率的相关风险因素尤为重要。本叙述性综述聚焦于核成像在肥厚型心肌病中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4061/11989881/15fe82a75faf/jcm-14-02183-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4061/11989881/15fe82a75faf/jcm-14-02183-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4061/11989881/15fe82a75faf/jcm-14-02183-g001.jpg

相似文献

1
The Utility of Nuclear Imaging in Hypertrophic Cardiomyopathy: A Narrative Review.核成像在肥厚型心肌病中的应用:一篇叙述性综述
J Clin Med. 2025 Mar 22;14(7):2183. doi: 10.3390/jcm14072183.
2
Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.用于评估心肌活力的正电子发射断层扫描:基于证据的分析。
Ont Health Technol Assess Ser. 2010;10(16):1-80. Epub 2010 Jul 1.
3
Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.用于评估心肌存活性的磁共振成像(MRI):一项基于证据的分析。
Ont Health Technol Assess Ser. 2010;10(15):1-45. Epub 2010 Jul 1.
4
Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy.心血管磁共振在肥厚型心肌病中的临床应用。
J Cardiovasc Magn Reson. 2012 Feb 1;14(1):13. doi: 10.1186/1532-429X-14-13.
5
Clinical topic: Nuclear imaging in hypertrophic cardiomyopathy.临床主题:肥厚型心肌病的核成像
J Nucl Cardiol. 2015 Jun;22(3):408-18. doi: 10.1007/s12350-014-0054-7. Epub 2014 Dec 30.
6
The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy.心血管磁共振成像在肥厚型心肌病中的现行和新兴作用。
J Cardiovasc Transl Res. 2009 Dec;2(4):415-25. doi: 10.1007/s12265-009-9136-3. Epub 2009 Nov 7.
7
Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.用于评估心肌活力的正电子发射断层扫描:一项基于证据的分析。
Ont Health Technol Assess Ser. 2005;5(16):1-167. Epub 2005 Oct 1.
8
PET-CT Imaging in Hypertrophic Cardiomyopathy: A Narrative Review on Risk Stratification and Prognosis.肥厚型心肌病的PET-CT成像:关于风险分层与预后的叙述性综述
Diagnostics (Basel). 2025 Jan 8;15(2):133. doi: 10.3390/diagnostics15020133.
9
The Role of Cardiac MRI in the Diagnosis and Risk Stratification of Hypertrophic Cardiomyopathy.心脏磁共振成像在肥厚型心肌病诊断及危险分层中的作用
Arrhythm Electrophysiol Rev. 2016;5(3):197-202. doi: 10.15420/aer.2016:13:3.
10
Dual-single photon emission computed tomography and contrast-enhanced magnetic resonance imaging to evaluate dissimilar features of apical hypertrophic cardiomyopathy.双单光子发射计算机断层扫描和对比增强磁共振成像评估心尖肥厚型心肌病的不同特征。
Cardiol J. 2010;17(3):306-11.

本文引用的文献

1
Molecular imaging in hypertrophic cardiomyopathy: an exploratory study with 2-[F]FDG and [N]NH.肥厚型心肌病的分子成像:一项使用2-[F]FDG和[N]NH的探索性研究。
EJNMMI Res. 2025 Feb 28;15(1):18. doi: 10.1186/s13550-025-01212-y.
2
Mechano-energetic uncoupling in hypertrophic cardiomyopathy: Pathophysiological mechanisms and therapeutic opportunities.肥厚型心肌病中的机械-能量解偶联:病理生理机制与治疗机遇
J Mol Cell Cardiol Plus. 2023 May 6;4:100036. doi: 10.1016/j.jmccpl.2023.100036. eCollection 2023 Jun.
3
Demographic-Based Personalized Left Ventricular Hypertrophy Thresholds for Hypertrophic Cardiomyopathy Diagnosis.
基于人口统计学的肥厚型心肌病诊断个性化左心室肥厚阈值
J Am Coll Cardiol. 2025 Feb 25;85(7):685-695. doi: 10.1016/j.jacc.2024.10.082. Epub 2025 Jan 8.
4
Enhanced detection of damaged myocardium and risk stratification in hypertrophic cardiomyopathy using integrated [Ga]Ga-FAPI-04 PET/CMR imaging.使用整合 [Ga]Ga-FAPI-04 PET/CMR 成像技术增强肥厚型心肌病中心肌损伤的检测和危险分层。
Eur J Nucl Med Mol Imaging. 2024 Dec;52(1):98-108. doi: 10.1007/s00259-024-06878-5. Epub 2024 Aug 24.
5
Genetics of hypertrophic cardiomyopathy: established and emerging implications for clinical practice.肥厚型心肌病的遗传学:对临床实践的既定和新出现的影响。
Eur Heart J. 2024 Aug 9;45(30):2727-2734. doi: 10.1093/eurheartj/ehae421.
6
Artificial Intelligence (AI) in Nuclear Medicine: Is a Friend Not Foe.核医学中的人工智能:是友非敌。
World J Nucl Med. 2024 Jan 22;23(1):1-2. doi: 10.1055/s-0043-1777698. eCollection 2024 Mar.
7
Functional significance of myocardial activity at F-FAPI PET/CT in hypertrophic cardiomyopathy identified by cardiac magnetic resonance feature-tracking strain analysis.心肌磁共振特征追踪应变分析识别肥厚型心肌病 F-FAPI PET/CT 心肌活性的功能意义。
Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):110-122. doi: 10.1007/s00259-023-06411-0. Epub 2023 Aug 29.
8
2023 ESC Guidelines for the management of cardiomyopathies.2023年欧洲心脏病学会心肌病管理指南。
Eur Heart J. 2023 Oct 1;44(37):3503-3626. doi: 10.1093/eurheartj/ehad194.
9
Multimodality imaging of hypertrophic cardiomyopathy.肥厚型心肌病的多模态成像
Prog Cardiovasc Dis. 2023 Sep-Oct;80:14-24. doi: 10.1016/j.pcad.2023.08.004. Epub 2023 Aug 14.
10
Galectin-3 as a novel biomarker in cats with hypertrophic cardiomyopathy.半乳糖凝集素-3 作为肥厚型心肌病猫的新型生物标志物。
J Vet Cardiol. 2023 Aug;48:54-62. doi: 10.1016/j.jvc.2023.06.003. Epub 2023 Jun 27.